ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IOSP Innospec Inc

121.65
1.65 (1.37%)
09 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Innospec Inc NASDAQ:IOSP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.65 1.37% 121.65 60.00 141.14 121.73 119.24 119.24 231,905 01:00:00

Current Report Filing (8-k)

03/08/2022 11:16am

Edgar (US Regulatory)


false 0001054905 0001054905 2022-08-02 2022-08-02

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 2, 2022

 

 

INNOSPEC INC.

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 1-13879

 

Delaware   98-0181725
(State or other jurisdiction
of incorporation)
  (IRS Employer
Identification No.)

8310 South Valley Highway, Suite 350

Englewood, Colorado, 80112

(Address of principal executive offices, including zip code)

(303)792-5554

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of exchange

on which registered

Common Stock   IOSP   NASDAQ

 

 

 


Item 2.02

Results of Operations and Financial Condition.

On August 2, 2022, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 30, 2022 (the “Press Release”).

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

EXHIBIT INDEX

 

Number

  

Description

  

Method of Filing

 
99.1    Press Release dated August 2, 2022 announcing Innospec Inc.’s financial results for the fiscal quarter ended June 30, 2022      Filed Herewith  
104   

Cover Page Interactive Data File – the cover page XBRL tags are embedded

within the Inline XBRL document.

  


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     

INNOSPEC INC.

Date: August 3, 2022

   

By:

 

/s/ David B. Jones

      David B. Jones
      Senior Vice President, General Counsel and Chief Compliance Officer

1 Year Innospec Chart

1 Year Innospec Chart

1 Month Innospec Chart

1 Month Innospec Chart

Your Recent History

Delayed Upgrade Clock